Dr. Kathleen Welsh-Bohmer is a Professor of Psychiatry with a secondary appointment in the Department of Neurology. She is also the Chief of the Medical Psychology CPU, the professional home for the over 200 academic psychologists within Duke Medical Center.
Clinically trained as a neuropsychologist, Dr. Welsh-Bohmer's research activities have been focused around developing effective prevention and treatment strategies to delay the onset of cognitive disorders occurring in later life. Since 2006 she has directed the Joseph and Kathleen Bryan Alzheimer’s Center in the Department of Neurology, where she leads a large multidisciplinary team focused on discovering the biological basis of Alzheimer’s disease and developing methods to enhance early diagnosis and speed drug discovery.
Currently, she oversees the neuropsychology scientific operations of a Phase III global clinical trial to delay the onset of Alzheimer’s disease entitled the “TOMMORROW” study (Takeda Pharmaceutical Company funded). The methods her team is developing for this study fill an information void and have implications for accelerating global clinical trials in Alzheimer’s disease prevention.
Education and Training
- Ph.D., University of Virginia, 1985
- Metabolic Signatures Underlying Vascular Risk Factors for Alzheimer-type Dementias
- Behavioral and Physiology in Aging
- Shared genetic, epigenetic, and transcriptomic profiles between AD and PTSD: molecular insights into the heterogeneity of neuropsychiatric symptoms in Alzheimers Disease
- White Matter Damage in Subconcussive Blast Exposure
- NC Registry for Brain Health
- Neuropsychology of Pre-dementia Alzheimer's Disease
- Impact of Disclosing Amyloid Imaging Results to Cognitively Normal Individuals
- Life Course Process of Alzheimer's Disease: Sex Difference and Biosocial Mechanisms
- Metabolic Networks and Pathways in Alzheimer's Disease
- T3D959-203 ALZHEIMER'S DISEASE